| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Morgan Stanley | 6,153,393 | 5,629,313 |
| Syros Pharmaceuticals, Inc. | 217,280 | 136,615 |
| Description | Amount |
|---|---|
| Cummulative unrecognized value of donated stock sold | 734,102 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Morgan Stanley - wire fee | 50 | 50 | 0 | |
| Morgan Stanley - Misc exp | 690 | 690 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Morgan Stanley #5942 | 14,088 | 14,088 | 14,088 |
| Morgan Stanley #2375 | 3,604 | 3,604 | 3,604 |
| Description | Amount |
|---|---|
| Unrealized change in investment value | 604,743 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Advisor Fees - Morgan Stanley #5942 | 42,034 | 42,034 | 0 |
| Name | Address |
|---|---|
| Noubar Afeyan |
55 Cambridge Parkway Suite 800A Cambridge,MA02142 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Taxes | 500 | 500 | 0 | |
| Foreign Tax Paid - Morgan Stanley #5942 | 3,549 | 3,549 | 0 |